Literature DB >> 4689898

Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.

J Vaage.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4689898

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.

Authors: 
Journal:  Br Med J       Date:  1975-08-23

2.  T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.

Authors:  M J Berendt; R J North
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

3.  Studies on the stimulation and suppression of deoxyribonucleic acid (DNA) synthesis in lymph node cells of mice bearing progressively growing tumours.

Authors:  K D Chandradasa; J Bradley
Journal:  Br J Cancer       Date:  1976-01       Impact factor: 7.640

Review 4.  Radiation-induced bystander and abscopal effects: important lessons from preclinical models.

Authors:  Elisabeth Daguenet; Safa Louati; Anne-Sophie Wozny; Nicolas Vial; Mathilde Gras; Jean-Baptiste Guy; Alexis Vallard; Claire Rodriguez-Lafrasse; Nicolas Magné
Journal:  Br J Cancer       Date:  2020-06-25       Impact factor: 7.640

Review 5.  Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system.

Authors:  Rebecca Anne Bekker; Sungjune Kim; Shari Pilon-Thomas; Heiko Enderling
Journal:  Neoplasia       Date:  2022-04-19       Impact factor: 6.218

Review 6.  Local Destruction of Tumors and Systemic Immune Effects.

Authors:  Karl-Göran Tranberg
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

7.  Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.

Authors:  D W Hedley; T J McElwain; G A Currie
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

8.  A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours.

Authors:  M Franco; O D Bustuoabad; P D di Gianni; A Goldman; C D Pasqualini; R A Ruggiero
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.